497 related articles for article (PubMed ID: 30283976)
1. Potential application of cell reprogramming techniques for cancer research.
Saito S; Lin YC; Nakamura Y; Eckner R; Wuputra K; Kuo KK; Lin CS; Yokoyama KK
Cell Mol Life Sci; 2019 Jan; 76(1):45-65. PubMed ID: 30283976
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
[TBL] [Abstract][Full Text] [Related]
3. Application of Cancer Cell Reprogramming Technology to Human Cancer Research.
Pan XY; Tsai MH; Wuputra K; Ku CC; Lin WH; Lin YC; Kishikawa S; Noguchi M; Saito S; Lin CS; Yokoyama KK
Anticancer Res; 2017 Jul; 37(7):3367-3377. PubMed ID: 28668824
[TBL] [Abstract][Full Text] [Related]
4. Linking Pluripotency Reprogramming and Cancer.
Iglesias JM; Gumuzio J; Martin AG
Stem Cells Transl Med; 2017 Feb; 6(2):335-339. PubMed ID: 28191771
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of cancer stem cells into non-tumorigenic cells using stem cell exosomes for cancer therapy.
Lee KS; Choi JS; Cho YW
Biochem Biophys Res Commun; 2019 May; 512(3):511-516. PubMed ID: 30905410
[TBL] [Abstract][Full Text] [Related]
6. Primitive Cancer Cell States: A Target for Drug Screening?
Wan ACA
Trends Pharmacol Sci; 2019 Mar; 40(3):161-171. PubMed ID: 30709543
[TBL] [Abstract][Full Text] [Related]
7. Parallels between artificial reprogramming and the biogenesis of cancer stem cells: Involvement of lncRNAs.
Rasmussen TP
Semin Cancer Biol; 2019 Aug; 57():36-44. PubMed ID: 30273656
[TBL] [Abstract][Full Text] [Related]
8. Stem cells in tissues, organoids, and cancers.
Wang X
Cell Mol Life Sci; 2019 Oct; 76(20):4043-4070. PubMed ID: 31317205
[TBL] [Abstract][Full Text] [Related]
9. Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.
Menendez JA; Alarcón T; Corominas-Faja B; Cuyàs E; López-Bonet E; Martin AG; Vellon L
Cell Cycle; 2014; 13(3):358-70. PubMed ID: 24406535
[TBL] [Abstract][Full Text] [Related]
10. Transdifferentiation and reprogramming: Overview of the processes, their similarities and differences.
Cieślar-Pobuda A; Knoflach V; Ringh MV; Stark J; Likus W; Siemianowicz K; Ghavami S; Hudecki A; Green JL; Łos MJ
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1359-1369. PubMed ID: 28460880
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic alterations involved in cancer stem cell reprogramming.
Muñoz P; Iliou MS; Esteller M
Mol Oncol; 2012 Dec; 6(6):620-36. PubMed ID: 23141800
[TBL] [Abstract][Full Text] [Related]
12. Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.
Lin YC; Ku CC; Wuputra K; Liu CJ; Wu DC; Satou M; Mitsui Y; Saito S; Yokoyama KK
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791215
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
Xie M; Tang S; Li K; Ding S
Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell: fundamental experimental pathological concepts and updates.
Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
[TBL] [Abstract][Full Text] [Related]
15. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.
Wuputra K; Ku CC; Wu DC; Lin YC; Saito S; Yokoyama KK
J Exp Clin Cancer Res; 2020 Jun; 39(1):100. PubMed ID: 32493501
[TBL] [Abstract][Full Text] [Related]
16. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
Shah M; Allegrucci C
Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
[TBL] [Abstract][Full Text] [Related]
17. 3D chromatin architecture and epigenetic regulation in cancer stem cells.
Feng Y; Liu X; Pauklin S
Protein Cell; 2021 Jun; 12(6):440-454. PubMed ID: 33453053
[TBL] [Abstract][Full Text] [Related]
18. Cellular reprogramming technology for dissecting cancer epigenome in vivo.
Ito K; Yamada Y
Epigenomics; 2017 Jul; 9(7):997-1011. PubMed ID: 28651445
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming lineage identity through cell-cell fusion.
Brown KE; Fisher AG
Curr Opin Genet Dev; 2021 Oct; 70():15-23. PubMed ID: 34087754
[TBL] [Abstract][Full Text] [Related]
20. Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells.
Scaffidi P; Misteli T
Cold Spring Harb Symp Quant Biol; 2010; 75():251-8. PubMed ID: 21047903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
